Is It Time To Reconsider Novartis (SWX:NOVN) After Its Recent Share Price Gains?
-
If you are wondering whether Novartis shares still offer value at around CHF 114.04, it starts with understanding how the current price lines up against a few different valuation checks.
-
The stock has returned 4.1% over the last 7 days, 8.1% over 30 days, 5.1% year to date, 29.7% over 1 year, 59.5% over 3 years and 71.0% over 5 years. This gives you some context before weighing up what you are paying today.
-
Behind these moves, investors have been focused on Novartis’ position as a major global pharmaceuticals and biotech company and how its portfolio and pipeline fit into long term healthcare demand. Broader sentiment toward large healthcare names has also been an important backdrop for how the market is currently pricing the…
